The expression of cytokine activity by fracture callus

Cytokines, a group of proteins known to regulate hemopoietic and immune functions, are also involved in inflammation, angiogenesis, and bone and cartilage metabolism. Since all of these processes occur following bone injury, or are known to contribute to wound repair mechanisms, this investigation sought to test the hypothesis that cytokines are involved in fracture healing. Two sets of 60 male Sprague‐Dawley rats underwent the production of standard closed femoral fractures. The animals were then euthanized in groups of 15 on days 3, 7, 14, and 21 postfracture. A separate control group was also used for the harvesting of intact unfractured bone. At the time of euthanasia, calluses or bone specimens were explanted to organ culture and treated with either media alone or media containing the inducing agents lipopolysaccharide or concanavalin A. A titration of conditioned medium from these cultures was then added to factor‐dependent clonal cell lines that are known to be specifically responsive to interleukin‐1, interleukin‐6, granulocyte‐macrophage colony stimulating factor or macrophage‐colony stimulating factor. To confirm the identities of each of these cytokines, neutralizing antibody studies were performed. The results showed that interleukin‐1 is expressed at very low constitutive levels throughout the period of fracture healing but can be induced to high activities in the early inflammatory phase (day 3). Granulocyte‐macrophage colony stimulating factor showed no constitutive activity but could also be induced to high activities with lipopolysaccharide. The ability of these two cytokines to be induced declined progressively as fracture healing proceeded. Interleukin‐6 showed high constitutive activity early in the healing process (day 3), and treatment with inducing agent did not increase the activity of this cytokine at this timepoint. Lipopolysaccharide did increase interleukin‐6 activity in day 7 and 14 fracture calluses. Although macrophage‐colony stimulating factor is thought to be involved in a variety of metabolic bone conditions, it could not be detected or induced from any of the callus samples. Moreover, none of the samples of unfractured bone showed constitutive or inducible activities for any of these cytokines. A separate experiment in which calluses and samples of unfractured bone from similar cultures were examined histologically and tested for DNA or protein synthesis at two timepoints in the culture period (days 1 and 4) showed that tissue viability was maintained. Thus the inability to detect macrophage colony‐stimulating factor in fracture callus or any cytokine activity in unfractured bones was not due to cell death. These findings suggest that the occurrence of a fracture results in a cascade of events that includes the production of cytokines. The time‐dependent expression of specific cytokine activities, which are differentially regulated, supports the concept that fracture healing may be partially mediated by these factors.

[1]  T. Einhorn,et al.  Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[3]  R. Baron,et al.  Macrophage colony‐stimulating factor release and receptor expression in bone cells , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  G. Roodman Perspectives: Interleukin‐6: An osteotropic factor? , 1992 .

[5]  I. Otterness,et al.  The beta form is the dominant interleukin 1 released by murine peritoneal macrophages. , 1989, Biochemical and biophysical research communications.

[6]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .

[7]  T. Kupper,et al.  Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). , 1987, Journal of immunology.

[8]  J. Merrill,et al.  Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. , 1991, Developmental neuroscience.

[9]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[10]  L. Aarden,et al.  Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. , 1989, Biochemical and biophysical research communications.

[11]  T. K. Hunt,et al.  Enhancement of wound healing by growth factors. , 1989, The New England journal of medicine.

[12]  F. D. Di Padova,et al.  Interleukin‐6 is produced by bone and modulated by parathyroid hormone , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  J. Elias,et al.  Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. , 1995, Endocrinology.

[14]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.

[15]  T. Kupper,et al.  Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor. , 1989, The Journal of clinical investigation.

[16]  C. Turck,et al.  Immunological mediators of wound healing and fibrosis , 1987, Journal of cellular physiology. Supplement.

[17]  C. Smith,et al.  Activation of an interleukin-1-responsive T-cell lymphoma by fixed P388D1 macrophages and an antibody against the Ag:MHC T-cell receptor. , 1985, Cellular immunology.

[18]  L. Aarden,et al.  Interleukin 6 is involved in interleukin 1‐induced activities , 1988, European journal of immunology.

[19]  A. Barbul,et al.  Interleukin 2 enhances wound healing in rats. , 1986, The Journal of surgical research.

[20]  D. Williams,et al.  Effect of enhanced macrophage function on early wound healing. , 1988, Surgery.

[21]  A. Hirschman,et al.  Neutral protein‐degrading enzymes in experimental fracture callus: A preliminary report , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  N. Nicola Hemopoietic cell growth factors and their receptors. , 1989, Annual review of biochemistry.

[24]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[25]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[26]  R. Russell,et al.  Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. , 1985, The Journal of clinical investigation.

[27]  L. Nanney,et al.  Enhancement of wound healing by topical treatment with epidermal growth factor. , 1989, The New England journal of medicine.

[28]  W. Philbrick,et al.  Functional and molecular changes in colony stimulating factor secretion by osteoblasts. , 1989, Connective tissue research.

[29]  T. Hirano,et al.  IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.

[30]  I. Otterness,et al.  Transition from interleukin 1 beta (IL-1 beta) to IL-1 alpha production during maturation of inflammatory macrophages in vivo , 1992, The Journal of experimental medicine.

[31]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.

[32]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.

[33]  R. Graham,et al.  Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. , 1984, Biochimica et biophysica acta.

[34]  C. March,et al.  Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines , 1986, The Journal of experimental medicine.

[35]  T. Einhorn,et al.  Osteotropic agents induce the differential secretion of granulocyte‐macrophage colony‐stimulating factor by the osteoblast cell line MC3T3‐E1 , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  R. Hembry,et al.  Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. , 1989, The Journal of bone and joint surgery. American volume.

[37]  R. Burger,et al.  Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11. , 1993, Journal of immunological methods.

[38]  M. Bolander,et al.  Transforming growth factor-beta in the regulation of fracture repair. , 1990, The Orthopedic clinics of North America.

[39]  B. Gliniak,et al.  Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF , 1990, Cell.

[40]  G. Möller,et al.  Selective induction of DNA synthesis in T and B lymphocytes. , 1972, Cellular immunology.

[41]  M. Redinbaugh,et al.  Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. , 1986, Analytical biochemistry.